Twist Bioscience Corp. Stock News

Twist Bioscience Corporation (TWST) CEO Emily Leprouston Q4 2020 Results - Earnings Call Transcript

Shares of Twist Bioscience (NASDAQ:TWST) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 43.75% year over year to ($0.54), which beat the estimate

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its s

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (Nasdaq: TWST) today announced preclinical data for three of its proprietary antibodies against the S1 protein in SARS

On Monday, November 23, Twist Bioscience (NASDAQ: TWST) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), today announced that it ranked 60th on Deloitte's Technology Fast 500™, a ranking of the 500 fastest

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its s